Federal prosecutors have charged the founders of the once-dominant auto parts supplier First Brands Group with orchestrating a massive, years-long fraud, alleging a scheme that misled lenders and ultimately led to the company's catastrophic bankruptcy, sending shockwaves through the industry.
The Detroit automaker has held preliminary talks with Xiaomi and other Chinese manufacturers about potential joint ventures to build electric vehicles in the United States, a move already drawing sharp criticism from Washington lawmakers.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
Following the finalization of a joint venture with investment firm CPE, Burger King's parent company RBI has reaffirmed ambitious plans to more than triple its footprint in China over the next decade, backed by a $350 million investment.
Following a sharp post-earnings sell-off, Intel CFO David Zinsner made a substantial open-market purchase of company stock, a move seen as a strong vote of confidence even as Wall Street analysts remain divided on the chipmaker's turnaround prospects.
Financial expert Suze Orman challenges conventional retirement targets, urging a defensive cash reserve of three to five years' expenses to shield against market volatility.
In a significant move to secure domestic supply chains for critical minerals, the U.S. government has taken a direct 15% equity position in MP Materials. This strategic investment, paired with expanded federal contracts, aims to reduce reliance on foreign sources for rare earths essential to defense and green energy technologies.
Aerospace giant Boeing is joining a major U.S. public-private initiative to build a national stockpile of critical minerals, a strategic move aimed at reducing dependence on foreign sources and bolstering domestic manufacturing resilience for defense and commercial programs.
GameStop shares rallied over 6% after CEO Ryan Cohen outlined a bold vision to transform the struggling retailer into a consumer sector powerhouse through strategic M&A, leveraging its substantial cash reserves.
STAAR Surgical's stock fell sharply after the ophthalmic device maker announced the appointment of interim co-CEOs, fueling investor uncertainty following the CEO's recent departure and a failed takeover attempt.
Shares of Columbia Financial (CLBK) rallied sharply after the community bank announced a definitive agreement to acquire Northfield Bancorp, a move set to create New Jersey's third-largest regional bank and significantly boost future earnings.
The Trump administration is moving to establish a major national stockpile of critical minerals, with a $10 billion federal loan and private investment, aiming to reduce reliance on foreign supplies for key technologies.
Regional banks like Fifth Third are betting on a historic profit surge if Kevin Warsh reshapes the Fed. But Wall Street warns his ambitious plan to slash rates and shrink the balance sheet faces fierce internal and political headwinds, threatening market stability.
Despite solid revenue growth, Microvast Holdings (NASDAQ: MVST) has seen its share price collapse over the past five years, erasing billions in market value and testing the patience of long-term investors.
As global demand for copper surges—driven by AI data centers, electrification, and green energy—a severe supply crunch looms. Mining magnate Robert Friedland warns of a looming 'train wreck,' putting companies like Southern Copper and Freeport-McMoRan in the spotlight for investors.
A landmark Senate hearing this week will examine the potential cultural and economic fallout of Netflix's proposed acquisition of Warner Bros. Discovery, amid fears it could create an unprecedented 'stream-opoly'.
Life sciences and diagnostics firm Revvity (RVTY) closed 2025 with results surpassing internal targets, driven by robust diagnostics performance. While management provided initial 2026 guidance, it remains conservative, banking on market stabilization rather than a broad recovery.
Hess Midstream Partners (HESM) capped off 2025 with robust operational results and the completion of its core infrastructure build-out. Management now signals a sharp pivot towards capital discipline, forecasting significantly lower spending through 2028 to fuel growing shareholder returns, even as severe winter weather tempers near-term volume expectations.
Aptiv capped off 2025 with record fourth-quarter sales and detailed a transformative 2026 outlook, headlined by the imminent spin-off of its Electrical Distribution Systems unit into VersaGen. The automotive tech leader is navigating currency headwinds and strategic investments to expand beyond traditional auto markets.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
